nodes	percent_of_prediction	percent_of_DWPC	metapath
Deferiprone—Fatigue—Vinorelbine—ovarian cancer	0.00166	0.00166	CcSEcCtD
Deferiprone—Hypersensitivity—Topotecan—ovarian cancer	0.00166	0.00166	CcSEcCtD
Deferiprone—Angiopathy—Paclitaxel—ovarian cancer	0.00166	0.00166	CcSEcCtD
Deferiprone—Pain—Vinorelbine—ovarian cancer	0.00165	0.00165	CcSEcCtD
Deferiprone—Immune system disorder—Paclitaxel—ovarian cancer	0.00165	0.00165	CcSEcCtD
Deferiprone—Mediastinal disorder—Paclitaxel—ovarian cancer	0.00164	0.00164	CcSEcCtD
Deferiprone—Chills—Paclitaxel—ovarian cancer	0.00164	0.00164	CcSEcCtD
Deferiprone—Hepatobiliary disease—Docetaxel—ovarian cancer	0.00163	0.00163	CcSEcCtD
Deferiprone—Hypersensitivity—Melphalan—ovarian cancer	0.00163	0.00163	CcSEcCtD
Deferiprone—Epistaxis—Docetaxel—ovarian cancer	0.00163	0.00163	CcSEcCtD
Deferiprone—Asthenia—Topotecan—ovarian cancer	0.00162	0.00162	CcSEcCtD
Deferiprone—Vomiting—Chlorambucil—ovarian cancer	0.00161	0.00161	CcSEcCtD
Deferiprone—Agranulocytosis—Docetaxel—ovarian cancer	0.00161	0.00161	CcSEcCtD
Deferiprone—Increased appetite—Epirubicin—ovarian cancer	0.00161	0.00161	CcSEcCtD
Deferiprone—Mental disorder—Paclitaxel—ovarian cancer	0.0016	0.0016	CcSEcCtD
Deferiprone—Pruritus—Topotecan—ovarian cancer	0.00159	0.00159	CcSEcCtD
Deferiprone—Malnutrition—Paclitaxel—ovarian cancer	0.00159	0.00159	CcSEcCtD
Deferiprone—Asthenia—Melphalan—ovarian cancer	0.00158	0.00158	CcSEcCtD
Deferiprone—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.00158	0.00158	CcSEcCtD
Deferiprone—Pruritus—Melphalan—ovarian cancer	0.00156	0.00156	CcSEcCtD
Deferiprone—Hepatitis—Docetaxel—ovarian cancer	0.00155	0.00155	CcSEcCtD
Deferiprone—Cardiac failure—Epirubicin—ovarian cancer	0.00155	0.00155	CcSEcCtD
Deferiprone—Diarrhoea—Topotecan—ovarian cancer	0.00154	0.00154	CcSEcCtD
Deferiprone—Back pain—Paclitaxel—ovarian cancer	0.00154	0.00154	CcSEcCtD
Deferiprone—Pharyngitis—Docetaxel—ovarian cancer	0.00154	0.00154	CcSEcCtD
Deferiprone—Urticaria—Vinorelbine—ovarian cancer	0.00153	0.00153	CcSEcCtD
Deferiprone—Urinary tract disorder—Docetaxel—ovarian cancer	0.00153	0.00153	CcSEcCtD
Deferiprone—Body temperature increased—Vinorelbine—ovarian cancer	0.00152	0.00152	CcSEcCtD
Deferiprone—Abdominal pain—Vinorelbine—ovarian cancer	0.00152	0.00152	CcSEcCtD
Deferiprone—Oedema peripheral—Docetaxel—ovarian cancer	0.00152	0.00152	CcSEcCtD
Deferiprone—Connective tissue disorder—Docetaxel—ovarian cancer	0.00152	0.00152	CcSEcCtD
Deferiprone—Urethral disorder—Docetaxel—ovarian cancer	0.00152	0.00152	CcSEcCtD
Deferiprone—Diarrhoea—Melphalan—ovarian cancer	0.00151	0.00151	CcSEcCtD
Deferiprone—Pain in extremity—Epirubicin—ovarian cancer	0.00151	0.00151	CcSEcCtD
Deferiprone—Diplopia—Epirubicin—ovarian cancer	0.00151	0.00151	CcSEcCtD
Deferiprone—Osteoarthritis—Epirubicin—ovarian cancer	0.00151	0.00151	CcSEcCtD
Deferiprone—Nausea—Chlorambucil—ovarian cancer	0.0015	0.0015	CcSEcCtD
Deferiprone—Increased appetite—Doxorubicin—ovarian cancer	0.00149	0.00149	CcSEcCtD
Deferiprone—Eye disorder—Docetaxel—ovarian cancer	0.00145	0.00145	CcSEcCtD
Deferiprone—Cardiac disorder—Docetaxel—ovarian cancer	0.00144	0.00144	CcSEcCtD
Deferiprone—Vomiting—Topotecan—ovarian cancer	0.00143	0.00143	CcSEcCtD
Deferiprone—Cardiac failure—Doxorubicin—ovarian cancer	0.00143	0.00143	CcSEcCtD
Deferiprone—Rash—Topotecan—ovarian cancer	0.00142	0.00142	CcSEcCtD
Deferiprone—Hypersensitivity—Vinorelbine—ovarian cancer	0.00142	0.00142	CcSEcCtD
Deferiprone—Dermatitis—Topotecan—ovarian cancer	0.00142	0.00142	CcSEcCtD
Deferiprone—Headache—Topotecan—ovarian cancer	0.00141	0.00141	CcSEcCtD
Deferiprone—Angiopathy—Docetaxel—ovarian cancer	0.0014	0.0014	CcSEcCtD
Deferiprone—Vomiting—Melphalan—ovarian cancer	0.0014	0.0014	CcSEcCtD
Deferiprone—Dehydration—Epirubicin—ovarian cancer	0.0014	0.0014	CcSEcCtD
Deferiprone—Immune system disorder—Docetaxel—ovarian cancer	0.0014	0.0014	CcSEcCtD
Deferiprone—Diplopia—Doxorubicin—ovarian cancer	0.0014	0.0014	CcSEcCtD
Deferiprone—Pain in extremity—Doxorubicin—ovarian cancer	0.0014	0.0014	CcSEcCtD
Deferiprone—Osteoarthritis—Doxorubicin—ovarian cancer	0.0014	0.0014	CcSEcCtD
Deferiprone—Mediastinal disorder—Docetaxel—ovarian cancer	0.00139	0.00139	CcSEcCtD
Deferiprone—Rash—Melphalan—ovarian cancer	0.00139	0.00139	CcSEcCtD
Deferiprone—Dermatitis—Melphalan—ovarian cancer	0.00139	0.00139	CcSEcCtD
Deferiprone—Chills—Docetaxel—ovarian cancer	0.00139	0.00139	CcSEcCtD
Deferiprone—Asthenia—Vinorelbine—ovarian cancer	0.00138	0.00138	CcSEcCtD
Deferiprone—Convulsion—Paclitaxel—ovarian cancer	0.00138	0.00138	CcSEcCtD
Deferiprone—Hypertension—Paclitaxel—ovarian cancer	0.00137	0.00137	CcSEcCtD
Deferiprone—Pruritus—Vinorelbine—ovarian cancer	0.00136	0.00136	CcSEcCtD
Deferiprone—Aspartate aminotransferase increased—Epirubicin—ovarian cancer	0.00136	0.00136	CcSEcCtD
Deferiprone—Mental disorder—Docetaxel—ovarian cancer	0.00136	0.00136	CcSEcCtD
Deferiprone—Arthralgia—Paclitaxel—ovarian cancer	0.00135	0.00135	CcSEcCtD
Deferiprone—Malnutrition—Docetaxel—ovarian cancer	0.00135	0.00135	CcSEcCtD
Deferiprone—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.00134	0.00134	CcSEcCtD
Deferiprone—Nausea—Topotecan—ovarian cancer	0.00134	0.00134	CcSEcCtD
Deferiprone—Discomfort—Paclitaxel—ovarian cancer	0.00134	0.00134	CcSEcCtD
Deferiprone—Alanine aminotransferase increased—Epirubicin—ovarian cancer	0.00133	0.00133	CcSEcCtD
Deferiprone—Diarrhoea—Vinorelbine—ovarian cancer	0.00132	0.00132	CcSEcCtD
Deferiprone—Nausea—Melphalan—ovarian cancer	0.00131	0.00131	CcSEcCtD
Deferiprone—Back pain—Docetaxel—ovarian cancer	0.0013	0.0013	CcSEcCtD
Deferiprone—Dehydration—Doxorubicin—ovarian cancer	0.0013	0.0013	CcSEcCtD
Deferiprone—Anaphylactic shock—Paclitaxel—ovarian cancer	0.0013	0.0013	CcSEcCtD
Deferiprone—Infection—Paclitaxel—ovarian cancer	0.00129	0.00129	CcSEcCtD
Deferiprone—Pancreatitis—Epirubicin—ovarian cancer	0.00128	0.00128	CcSEcCtD
Deferiprone—Nervous system disorder—Paclitaxel—ovarian cancer	0.00127	0.00127	CcSEcCtD
Deferiprone—Skin disorder—Paclitaxel—ovarian cancer	0.00126	0.00126	CcSEcCtD
Deferiprone—Aspartate aminotransferase increased—Doxorubicin—ovarian cancer	0.00126	0.00126	CcSEcCtD
Deferiprone—Hyperhidrosis—Paclitaxel—ovarian cancer	0.00125	0.00125	CcSEcCtD
Deferiprone—Pancytopenia—Epirubicin—ovarian cancer	0.00124	0.00124	CcSEcCtD
Deferiprone—Alanine aminotransferase increased—Doxorubicin—ovarian cancer	0.00123	0.00123	CcSEcCtD
Deferiprone—Vomiting—Vinorelbine—ovarian cancer	0.00123	0.00123	CcSEcCtD
Deferiprone—Neutropenia—Epirubicin—ovarian cancer	0.00122	0.00122	CcSEcCtD
Deferiprone—Rash—Vinorelbine—ovarian cancer	0.00122	0.00122	CcSEcCtD
Deferiprone—Dermatitis—Vinorelbine—ovarian cancer	0.00121	0.00121	CcSEcCtD
Deferiprone—Hypotension—Paclitaxel—ovarian cancer	0.00121	0.00121	CcSEcCtD
Deferiprone—Headache—Vinorelbine—ovarian cancer	0.00121	0.00121	CcSEcCtD
Deferiprone—Photosensitivity reaction—Epirubicin—ovarian cancer	0.00119	0.00119	CcSEcCtD
Deferiprone—Weight increased—Epirubicin—ovarian cancer	0.00119	0.00119	CcSEcCtD
Deferiprone—Pancreatitis—Doxorubicin—ovarian cancer	0.00118	0.00118	CcSEcCtD
Deferiprone—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.00118	0.00118	CcSEcCtD
Deferiprone—Pneumonia—Epirubicin—ovarian cancer	0.00117	0.00117	CcSEcCtD
Deferiprone—Convulsion—Docetaxel—ovarian cancer	0.00117	0.00117	CcSEcCtD
Deferiprone—Hypertension—Docetaxel—ovarian cancer	0.00116	0.00116	CcSEcCtD
Deferiprone—Infestation—Epirubicin—ovarian cancer	0.00116	0.00116	CcSEcCtD
Deferiprone—Infestation NOS—Epirubicin—ovarian cancer	0.00116	0.00116	CcSEcCtD
Deferiprone—Somnolence—Paclitaxel—ovarian cancer	0.00115	0.00115	CcSEcCtD
Deferiprone—Arthralgia—Docetaxel—ovarian cancer	0.00115	0.00115	CcSEcCtD
Deferiprone—Pancytopenia—Doxorubicin—ovarian cancer	0.00115	0.00115	CcSEcCtD
Deferiprone—Nausea—Vinorelbine—ovarian cancer	0.00114	0.00114	CcSEcCtD
Deferiprone—Dyspepsia—Paclitaxel—ovarian cancer	0.00114	0.00114	CcSEcCtD
Deferiprone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.00114	0.00114	CcSEcCtD
Deferiprone—Jaundice—Epirubicin—ovarian cancer	0.00113	0.00113	CcSEcCtD
Deferiprone—Neutropenia—Doxorubicin—ovarian cancer	0.00113	0.00113	CcSEcCtD
Deferiprone—Decreased appetite—Paclitaxel—ovarian cancer	0.00113	0.00113	CcSEcCtD
Deferiprone—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.00112	0.00112	CcSEcCtD
Deferiprone—Fatigue—Paclitaxel—ovarian cancer	0.00112	0.00112	CcSEcCtD
Deferiprone—Pain—Paclitaxel—ovarian cancer	0.00111	0.00111	CcSEcCtD
Deferiprone—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.0011	0.0011	CcSEcCtD
Deferiprone—Hepatobiliary disease—Epirubicin—ovarian cancer	0.0011	0.0011	CcSEcCtD
Deferiprone—Anaphylactic shock—Docetaxel—ovarian cancer	0.0011	0.0011	CcSEcCtD
Deferiprone—Weight increased—Doxorubicin—ovarian cancer	0.0011	0.0011	CcSEcCtD
Deferiprone—Epistaxis—Epirubicin—ovarian cancer	0.0011	0.0011	CcSEcCtD
Deferiprone—Infection—Docetaxel—ovarian cancer	0.00109	0.00109	CcSEcCtD
Deferiprone—Agranulocytosis—Epirubicin—ovarian cancer	0.00108	0.00108	CcSEcCtD
Deferiprone—Pneumonia—Doxorubicin—ovarian cancer	0.00108	0.00108	CcSEcCtD
Deferiprone—Nervous system disorder—Docetaxel—ovarian cancer	0.00108	0.00108	CcSEcCtD
Deferiprone—Infestation NOS—Doxorubicin—ovarian cancer	0.00108	0.00108	CcSEcCtD
Deferiprone—Infestation—Doxorubicin—ovarian cancer	0.00108	0.00108	CcSEcCtD
Deferiprone—Skin disorder—Docetaxel—ovarian cancer	0.00107	0.00107	CcSEcCtD
Deferiprone—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.00106	0.00106	CcSEcCtD
Deferiprone—Jaundice—Doxorubicin—ovarian cancer	0.00105	0.00105	CcSEcCtD
Deferiprone—Hepatitis—Epirubicin—ovarian cancer	0.00104	0.00104	CcSEcCtD
Deferiprone—Pharyngitis—Epirubicin—ovarian cancer	0.00104	0.00104	CcSEcCtD
Deferiprone—Urinary tract disorder—Epirubicin—ovarian cancer	0.00103	0.00103	CcSEcCtD
Deferiprone—Urticaria—Paclitaxel—ovarian cancer	0.00103	0.00103	CcSEcCtD
Deferiprone—Oedema peripheral—Epirubicin—ovarian cancer	0.00103	0.00103	CcSEcCtD
Deferiprone—Hypotension—Docetaxel—ovarian cancer	0.00103	0.00103	CcSEcCtD
Deferiprone—Connective tissue disorder—Epirubicin—ovarian cancer	0.00103	0.00103	CcSEcCtD
Deferiprone—Abdominal pain—Paclitaxel—ovarian cancer	0.00102	0.00102	CcSEcCtD
Deferiprone—Body temperature increased—Paclitaxel—ovarian cancer	0.00102	0.00102	CcSEcCtD
Deferiprone—Urethral disorder—Epirubicin—ovarian cancer	0.00102	0.00102	CcSEcCtD
Deferiprone—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.00102	0.00102	CcSEcCtD
Deferiprone—Epistaxis—Doxorubicin—ovarian cancer	0.00101	0.00101	CcSEcCtD
Deferiprone—Agranulocytosis—Doxorubicin—ovarian cancer	0.001	0.001	CcSEcCtD
Deferiprone—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.001	0.001	CcSEcCtD
Deferiprone—Somnolence—Docetaxel—ovarian cancer	0.000977	0.000977	CcSEcCtD
Deferiprone—Eye disorder—Epirubicin—ovarian cancer	0.000975	0.000975	CcSEcCtD
Deferiprone—Cardiac disorder—Epirubicin—ovarian cancer	0.000968	0.000968	CcSEcCtD
Deferiprone—Dyspepsia—Docetaxel—ovarian cancer	0.000967	0.000967	CcSEcCtD
Deferiprone—Hepatitis—Doxorubicin—ovarian cancer	0.000965	0.000965	CcSEcCtD
Deferiprone—Pharyngitis—Doxorubicin—ovarian cancer	0.000958	0.000958	CcSEcCtD
Deferiprone—Decreased appetite—Docetaxel—ovarian cancer	0.000955	0.000955	CcSEcCtD
Deferiprone—Hypersensitivity—Paclitaxel—ovarian cancer	0.000955	0.000955	CcSEcCtD
Deferiprone—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000953	0.000953	CcSEcCtD
Deferiprone—Oedema peripheral—Doxorubicin—ovarian cancer	0.000951	0.000951	CcSEcCtD
Deferiprone—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000949	0.000949	CcSEcCtD
Deferiprone—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000949	0.000949	CcSEcCtD
Deferiprone—Fatigue—Docetaxel—ovarian cancer	0.000947	0.000947	CcSEcCtD
Deferiprone—Angiopathy—Epirubicin—ovarian cancer	0.000947	0.000947	CcSEcCtD
Deferiprone—Urethral disorder—Doxorubicin—ovarian cancer	0.000946	0.000946	CcSEcCtD
Deferiprone—Immune system disorder—Epirubicin—ovarian cancer	0.000942	0.000942	CcSEcCtD
Deferiprone—Mediastinal disorder—Epirubicin—ovarian cancer	0.00094	0.00094	CcSEcCtD
Deferiprone—Pain—Docetaxel—ovarian cancer	0.00094	0.00094	CcSEcCtD
Deferiprone—Chills—Epirubicin—ovarian cancer	0.000936	0.000936	CcSEcCtD
Deferiprone—Asthenia—Paclitaxel—ovarian cancer	0.00093	0.00093	CcSEcCtD
Deferiprone—Pruritus—Paclitaxel—ovarian cancer	0.000917	0.000917	CcSEcCtD
Deferiprone—Mental disorder—Epirubicin—ovarian cancer	0.000914	0.000914	CcSEcCtD
Deferiprone—Malnutrition—Epirubicin—ovarian cancer	0.000908	0.000908	CcSEcCtD
Deferiprone—Eye disorder—Doxorubicin—ovarian cancer	0.000902	0.000902	CcSEcCtD
Deferiprone—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000899	0.000899	CcSEcCtD
Deferiprone—Cardiac disorder—Doxorubicin—ovarian cancer	0.000896	0.000896	CcSEcCtD
Deferiprone—Diarrhoea—Paclitaxel—ovarian cancer	0.000887	0.000887	CcSEcCtD
Deferiprone—Back pain—Epirubicin—ovarian cancer	0.000878	0.000878	CcSEcCtD
Deferiprone—Angiopathy—Doxorubicin—ovarian cancer	0.000876	0.000876	CcSEcCtD
Deferiprone—Immune system disorder—Doxorubicin—ovarian cancer	0.000872	0.000872	CcSEcCtD
Deferiprone—Mediastinal disorder—Doxorubicin—ovarian cancer	0.00087	0.00087	CcSEcCtD
Deferiprone—Body temperature increased—Docetaxel—ovarian cancer	0.000869	0.000869	CcSEcCtD
Deferiprone—Abdominal pain—Docetaxel—ovarian cancer	0.000869	0.000869	CcSEcCtD
Deferiprone—Chills—Doxorubicin—ovarian cancer	0.000866	0.000866	CcSEcCtD
Deferiprone—Mental disorder—Doxorubicin—ovarian cancer	0.000846	0.000846	CcSEcCtD
Deferiprone—Malnutrition—Doxorubicin—ovarian cancer	0.00084	0.00084	CcSEcCtD
Deferiprone—Vomiting—Paclitaxel—ovarian cancer	0.000824	0.000824	CcSEcCtD
Deferiprone—Rash—Paclitaxel—ovarian cancer	0.000817	0.000817	CcSEcCtD
Deferiprone—Dermatitis—Paclitaxel—ovarian cancer	0.000817	0.000817	CcSEcCtD
Deferiprone—Back pain—Doxorubicin—ovarian cancer	0.000813	0.000813	CcSEcCtD
Deferiprone—Headache—Paclitaxel—ovarian cancer	0.000812	0.000812	CcSEcCtD
Deferiprone—Hypersensitivity—Docetaxel—ovarian cancer	0.00081	0.00081	CcSEcCtD
Deferiprone—Asthenia—Docetaxel—ovarian cancer	0.000788	0.000788	CcSEcCtD
Deferiprone—Convulsion—Epirubicin—ovarian cancer	0.000787	0.000787	CcSEcCtD
Deferiprone—Hypertension—Epirubicin—ovarian cancer	0.000784	0.000784	CcSEcCtD
Deferiprone—Pruritus—Docetaxel—ovarian cancer	0.000777	0.000777	CcSEcCtD
Deferiprone—Arthralgia—Epirubicin—ovarian cancer	0.000773	0.000773	CcSEcCtD
Deferiprone—Nausea—Paclitaxel—ovarian cancer	0.00077	0.00077	CcSEcCtD
Deferiprone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000768	0.000768	CcSEcCtD
Deferiprone—Discomfort—Epirubicin—ovarian cancer	0.000764	0.000764	CcSEcCtD
Deferiprone—Diarrhoea—Docetaxel—ovarian cancer	0.000752	0.000752	CcSEcCtD
Deferiprone—Anaphylactic shock—Epirubicin—ovarian cancer	0.000741	0.000741	CcSEcCtD
Deferiprone—Infection—Epirubicin—ovarian cancer	0.000736	0.000736	CcSEcCtD
Deferiprone—Convulsion—Doxorubicin—ovarian cancer	0.000728	0.000728	CcSEcCtD
Deferiprone—Nervous system disorder—Epirubicin—ovarian cancer	0.000727	0.000727	CcSEcCtD
Deferiprone—Hypertension—Doxorubicin—ovarian cancer	0.000726	0.000726	CcSEcCtD
Deferiprone—Skin disorder—Epirubicin—ovarian cancer	0.00072	0.00072	CcSEcCtD
Deferiprone—Hyperhidrosis—Epirubicin—ovarian cancer	0.000717	0.000717	CcSEcCtD
Deferiprone—Arthralgia—Doxorubicin—ovarian cancer	0.000715	0.000715	CcSEcCtD
Deferiprone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.00071	0.00071	CcSEcCtD
Deferiprone—Discomfort—Doxorubicin—ovarian cancer	0.000707	0.000707	CcSEcCtD
Deferiprone—Vomiting—Docetaxel—ovarian cancer	0.000699	0.000699	CcSEcCtD
Deferiprone—Rash—Docetaxel—ovarian cancer	0.000693	0.000693	CcSEcCtD
Deferiprone—Hypotension—Epirubicin—ovarian cancer	0.000693	0.000693	CcSEcCtD
Deferiprone—Dermatitis—Docetaxel—ovarian cancer	0.000692	0.000692	CcSEcCtD
Deferiprone—Headache—Docetaxel—ovarian cancer	0.000688	0.000688	CcSEcCtD
Deferiprone—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000686	0.000686	CcSEcCtD
Deferiprone—Infection—Doxorubicin—ovarian cancer	0.000681	0.000681	CcSEcCtD
Deferiprone—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000675	0.000675	CcSEcCtD
Deferiprone—Nervous system disorder—Doxorubicin—ovarian cancer	0.000673	0.000673	CcSEcCtD
Deferiprone—Skin disorder—Doxorubicin—ovarian cancer	0.000666	0.000666	CcSEcCtD
Deferiprone—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000663	0.000663	CcSEcCtD
Deferiprone—Somnolence—Epirubicin—ovarian cancer	0.000659	0.000659	CcSEcCtD
Deferiprone—Nausea—Docetaxel—ovarian cancer	0.000653	0.000653	CcSEcCtD
Deferiprone—Dyspepsia—Epirubicin—ovarian cancer	0.000652	0.000652	CcSEcCtD
Deferiprone—Decreased appetite—Epirubicin—ovarian cancer	0.000644	0.000644	CcSEcCtD
Deferiprone—Hypotension—Doxorubicin—ovarian cancer	0.000641	0.000641	CcSEcCtD
Deferiprone—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.00064	0.00064	CcSEcCtD
Deferiprone—Fatigue—Epirubicin—ovarian cancer	0.000639	0.000639	CcSEcCtD
Deferiprone—Pain—Epirubicin—ovarian cancer	0.000634	0.000634	CcSEcCtD
Deferiprone—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000625	0.000625	CcSEcCtD
Deferiprone—Somnolence—Doxorubicin—ovarian cancer	0.00061	0.00061	CcSEcCtD
Deferiprone—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000606	0.000606	CcSEcCtD
Deferiprone—Dyspepsia—Doxorubicin—ovarian cancer	0.000604	0.000604	CcSEcCtD
Deferiprone—Decreased appetite—Doxorubicin—ovarian cancer	0.000596	0.000596	CcSEcCtD
Deferiprone—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000592	0.000592	CcSEcCtD
Deferiprone—Fatigue—Doxorubicin—ovarian cancer	0.000591	0.000591	CcSEcCtD
Deferiprone—Urticaria—Epirubicin—ovarian cancer	0.000589	0.000589	CcSEcCtD
Deferiprone—Pain—Doxorubicin—ovarian cancer	0.000586	0.000586	CcSEcCtD
Deferiprone—Abdominal pain—Epirubicin—ovarian cancer	0.000586	0.000586	CcSEcCtD
Deferiprone—Body temperature increased—Epirubicin—ovarian cancer	0.000586	0.000586	CcSEcCtD
Deferiprone—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000561	0.000561	CcSEcCtD
Deferiprone—Hypersensitivity—Epirubicin—ovarian cancer	0.000546	0.000546	CcSEcCtD
Deferiprone—Urticaria—Doxorubicin—ovarian cancer	0.000545	0.000545	CcSEcCtD
Deferiprone—Abdominal pain—Doxorubicin—ovarian cancer	0.000542	0.000542	CcSEcCtD
Deferiprone—Body temperature increased—Doxorubicin—ovarian cancer	0.000542	0.000542	CcSEcCtD
Deferiprone—Asthenia—Epirubicin—ovarian cancer	0.000532	0.000532	CcSEcCtD
Deferiprone—Pruritus—Epirubicin—ovarian cancer	0.000524	0.000524	CcSEcCtD
Deferiprone—Diarrhoea—Epirubicin—ovarian cancer	0.000507	0.000507	CcSEcCtD
Deferiprone—Hypersensitivity—Doxorubicin—ovarian cancer	0.000505	0.000505	CcSEcCtD
Deferiprone—Asthenia—Doxorubicin—ovarian cancer	0.000492	0.000492	CcSEcCtD
Deferiprone—Pruritus—Doxorubicin—ovarian cancer	0.000485	0.000485	CcSEcCtD
Deferiprone—Vomiting—Epirubicin—ovarian cancer	0.000471	0.000471	CcSEcCtD
Deferiprone—Diarrhoea—Doxorubicin—ovarian cancer	0.000469	0.000469	CcSEcCtD
Deferiprone—Rash—Epirubicin—ovarian cancer	0.000467	0.000467	CcSEcCtD
Deferiprone—Dermatitis—Epirubicin—ovarian cancer	0.000467	0.000467	CcSEcCtD
Deferiprone—Headache—Epirubicin—ovarian cancer	0.000464	0.000464	CcSEcCtD
Deferiprone—Nausea—Epirubicin—ovarian cancer	0.00044	0.00044	CcSEcCtD
Deferiprone—Vomiting—Doxorubicin—ovarian cancer	0.000436	0.000436	CcSEcCtD
Deferiprone—Rash—Doxorubicin—ovarian cancer	0.000432	0.000432	CcSEcCtD
Deferiprone—Dermatitis—Doxorubicin—ovarian cancer	0.000432	0.000432	CcSEcCtD
Deferiprone—Headache—Doxorubicin—ovarian cancer	0.00043	0.00043	CcSEcCtD
Deferiprone—Nausea—Doxorubicin—ovarian cancer	0.000407	0.000407	CcSEcCtD
